http://www.xconomy.com/seattle/2009/04/28/dendreon-clinical-trial-primer-what-you-need-to-know-about-todays-provenge-data/ Business + Technology in the Exponential Economy Sun, 22 Nov 2009 18:08:03 -0600 http://wordpress.org/?v=2.8.6 hourly 1 http://www.xconomy.com/seattle/2009/04/28/dendreon-clinical-trial-primer-what-you-need-to-know-about-todays-provenge-data/comment-page-1/#comment-55390 The Medical Quack: Dendreon Day - What Got People More Excited, the Announcement or the Stock? Wed, 29 Apr 2009 07:44:17 +0000 http://www.xconomy.com/?p=21950#comment-55390 [...] in the day, we reported what readers needed to remember about the context of this trial, and then we reported the most essential facts when the data appeared. A clinical trial of 512 men, [...] [...] in the day, we reported what readers needed to remember about the context of this trial, and then we reported the most essential facts when the data appeared. A clinical trial of 512 men, [...]

]]> http://www.xconomy.com/seattle/2009/04/28/dendreon-clinical-trial-primer-what-you-need-to-know-about-todays-provenge-data/comment-page-1/#comment-55268 Dendreon Presenting Today at AUA | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes Sneaky Tue, 28 Apr 2009 17:41:49 +0000 http://www.xconomy.com/?p=21950#comment-55268 [...] Xconomy has also done a great take on PROVENGE and what to expect at today’s meeting. [...] [...] Xconomy has also done a great take on PROVENGE and what to expect at today’s meeting. [...]

]]> http://www.xconomy.com/seattle/2009/04/28/dendreon-clinical-trial-primer-what-you-need-to-know-about-todays-provenge-data/comment-page-1/#comment-55267 DNDN Update, Stock Down 40% Ahead of Presentation!!! | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes Sneaky Tue, 28 Apr 2009 17:41:00 +0000 http://www.xconomy.com/?p=21950#comment-55267 [...] Xconomy has also done a great take on PROVENGE and what to expect at today’s meeting. [...] [...] Xconomy has also done a great take on PROVENGE and what to expect at today’s meeting. [...]

]]>